acf domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6121disable-gutenberg domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6121
NGP has been established by The Neuro in order to bring together several private and public actors around the common objective of better understanding the nervous system, discover mechanisms of disease and develop and deliver much needed early diagnostic modalities and effective treatments for neurological diseases.
With this partnership, the NGP will bring about a step change in the discovery process for brain diseases by harnessing and integrating recent advances in genomics, big data, Open Science and the unique patient populations followed at the Neuro and in Quebec. The approach will shed light on disease mechanisms, identify new human biology-based targets and accelerate the development of innovative therapies.
NGP is taking the next leap into integrative neuroscience
Better interlink datasets coming from increasingly complete picture of the brain and its functioning and organization (molecules, cells, micro-circuits, brain areas). Open science + harmonization from multiple initiatives
Better stratification and simulation of brain diseases
Better understand the precise relationship between genes and phenotype and the stratification of diseases into subtypes according to their underlying biological mechanism
Real academic and industrial collaboration
The Neuro C-BIG is the first Open Science biorepository for patients with neurological disease and healthy controls and an open access resource for the global scientific community.
Learn more (https://www.mcgill.ca/neuro/open-science/c-big-repository)
1.Train the next generation of researchers to work with induced pluripotent stem cells (iPSCs) 2.Translate fundamental research and technology into industry-standard assays 3.Identify new and improved treatments for neurological disorder
Learn more(https://www.mcgill.ca/neuro/open-science/eddu)
The Quebec Parkinson Network’s main mission is to join forces. It is a movement to promote multidisciplinary research on Parkinson’s disease. This gathering covers three essential elements for the conduct of large-scale research projects:
Learn more (https://rpq-qpn.ca/en)
The Clinical Research Unit at The Neuro (Montreal Neurological Institute-Hospital) is an internationally renowned neurological clinical research center affiliated with McGill University.
Learn more (https://cru.mcgill.ca/)
A pan-Canada initiative bridging people, data, and resources to accelerate Parkinson’s disease discoveries. Its Goal is to efficiently support Parkinson’s research to ultimately improve the lives of those living with the disease.
C-OPN includes Nine of Canada’s top universities and movement disorders research centres in Canada across 4 provinces (British Columbia, Alberta, Ontario and Quebec)
Learn more (https://cru.mcgill.ca/)
The Enfant Jesus Hospital offers specialized and sub-specialized care in a variety of fields, including neuroscience. Inspired by the people who make up its daily life, the hospital strives for excellence and offers care and services marked by humanism. With its recognized vision and knowledge, it contributes to numerous projects in the fields of health, science and knowledge sharing.
Learn more (https://www.chudequebec.ca/centre-hospitaliers/hopital-de-l-enfant-jesus.aspx)
lotam text
CEO
ACF
BGT
